Barclays raised the firm's price target on Dayforce to $84 from $80 and keeps an Equal Weight rating on the shares. With software "back in favor again," valuation levels have now caught up to historic
Barclays raised the firm's price target on Datadog to $187 from $155 and keeps an Overweight rating on the shares. With software "back in favor again," valuation levels have now caught up to historica
Barclays analyst Raimo Lenschow raised the firm's price target on Appian to $37 from $34 and keeps an Underweight rating on the shares. With software "back in favor again," valuation levels have now c
Barclays raised the firm's price target on American Airlines to $18 from $16 and keeps an Equal Weight rating on the shares. The firm sees a bullish setup for the North American airlines in 2025 as yi
Shares of American Airlines Group (AAL) soared 15% Thursday after the carrier announced it had signed a new, exclusive credit card partnership with Citi (C), which will be taking over Barclays' (BCS)
Shares of American Airlines Group (AAL) soared 11% Thursday after the carrier announced it had signed a new, exclusive credit card partnership with Citi (C), which will be taking over Barclays' (BCS)
American Airlines chooses Citi as sole credit card partner, drops Barclays
CHICAGO--(BUSINESS WIRE)--Motorola Solutions (NYSE:MSI) today announced that Mahesh Saptharishi, Executive Vice President and CTO, will participate in a fireside chat at the upcoming Barclays Global T
BCS agrees to settle the lawsuit concerning securities fraud for overselling its debt securities by paying $19.5 million in charges.
MOUNTAIN VIEW, Calif., Dec. 04, 2024 (GLOBE NEWSWIRE) -- LegalZoom (Nasdaq: LZ) today announced that Jeff Stibel, Chairman and Chief Executive Officer, and Noel Watson, Chief Operating Officer and Chi
Barclays has agreed to pay $19.5 million to settle a securities fraud lawsuit filed by shareholders in Manhattan federal court, over its misstep in selling $17.7 billion more debt than US regulators h
Barclays agreed to pay $19.5 million to settle a lawsuit in Manhattan by shareholders who accused the British bank of securities fraud after it sold $17.7 billion more debt than regulators allowed.
Are you not entertained? If Russel Crowe's legendary gladiatorial hero Maximus Decimus Meridius were to posit this question to UK consumers in November 2024, the answer would be a resounding yes.
Barclays CEO C.S. Venkatakrishnan said he was looking forward to being "useful" to the British bank "for some time to come", in a discussion about its CEO succession planning at a conference on Tuesda
Barclays raised the firm's price target on PTC Therapeutics to $56 from $45 and keeps an Equal Weight rating on the shares. The company's deal with Novartis is favorable with high upfront payment and
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE